Cargando…

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis

Various studies have assessed the clinicopathological and prognostic value of Notch1 and Notch3 expression in Non-small cell lung cancer (NSCLC), but their results remain controversial. This meta-analysis was conducted to address the above issues by using a total of 19 studies involving 3663 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Xun, Wu, Hua, Xu, Hanxiao, Han, Na, Chu, Qian, Yu, Shiying, Chen, Yuan, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440529/ https://www.ncbi.nlm.nih.gov/pubmed/25996086 http://dx.doi.org/10.1038/srep10338

Ejemplares similares

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
por: Yuan, Xun, et al.
Publicado: (2014)

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling
por: Han, Na, et al.
Publicado: (2015)

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
por: Xu, Hanxiao, et al.
Publicado: (2016)

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway
por: Huang, Shanshan, et al.
Publicado: (2022)

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
por: Sun, Wei, et al.
Publicado: (2015)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
por: Chu, Qian, et al.
Publicado: (2014)

Emerging roles of Nrf2 signal in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

NOTCH4 Is a Novel Prognostic Marker that Correlates with Colorectal Cancer Progression and Prognosis
por: Wu, Guiyang, et al.
Publicado: (2018)

DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
por: Liu, Yu, et al.
Publicado: (2015)

CD44 as a tumor biomarker and therapeutic target
por: Xu, Hanxiao, et al.
Publicado: (2020)

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

Prognostic significance of KRT19 in Lung Squamous Cancer
por: Yuan, Xun, et al.
Publicado: (2021)

Notch signaling pathway: architecture, disease, and therapeutics
por: Zhou, Binghan, et al.
Publicado: (2022)

Recent advances of highly selective CDK4/6 inhibitors in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2017)

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers
por: Tian, Yijun, et al.
Publicado: (2017)

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
por: Bai, Xianguang, et al.
Publicado: (2018)

CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis
por: Yang, Yong, et al.
Publicado: (2021)

DACH1 suppresses breast cancer as a negative regulator of CD44
por: Xu, Hanxiao, et al.
Publicado: (2017)

EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
por: Xu, Hanxiao, et al.
Publicado: (2019)

Recent advances of bispecific antibodies in solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
por: Xu, Hanxiao, et al.
Publicado: (2018)

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis
por: Xu, Han-Xiao, et al.
Publicado: (2016)

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
por: Yuan, Xun, et al.
Publicado: (2016)

Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis
por: Yi, Ming, et al.
Publicado: (2020)

Gut microbiome modulates efficacy of immune checkpoint inhibitors
por: Yi, Ming, et al.
Publicado: (2018)

Endogenous Dach1 in cancer
por: Wu, Kongming, et al.
Publicado: (2015)

CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer
por: Yu, Shengnan, et al.
Publicado: (2020)

Platelet distribution width correlates with prognosis of non-small cell lung cancer
por: Cui, Ming-ming, et al.
Publicado: (2017)

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
por: Liu, Qian, et al.
Publicado: (2018)

Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer
por: Wang, Yichao, et al.
Publicado: (2018)

Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
por: Zhang, Yingshi, et al.
Publicado: (2017)

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
por: Liu, Qian, et al.
Publicado: (2022)

Tumor organoids: applications in cancer modeling and potentials in precision medicine
por: Xu, Hanxiao, et al.
Publicado: (2022)

The clinical significance of CXCL5 in non-small cell lung cancer
por: Wu, Kongju, et al.
Publicado: (2017)

The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis
por: Wu, Kongju, et al.
Publicado: (2019)

Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
por: Qin, Shuang, et al.
Publicado: (2020)

Notch1 phenotype and clinical stage progression in non-small cell lung cancer
por: Nguyen, Dat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vpoormmeo0ct8hv0qfm1ho1s2e